Results 161 to 170 of about 3,564,396 (291)

Assessing research and researchers

, 2017
Henriikka Mustajoki, Arto Mustajoki
openaire   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

The san francisco declaration on research assessment. [PDF]

Biol Open, 2013
Raff JW.
europepmc   +2 more sources

Grand Challenges in Measuring and Characterizing Scholarly Impact

Frontiers in Research Metrics and Analytics, 2016
Chaomei Chen
doaj   +1 more source

The Relationship Between Dance Training Volume, Body Composition, and Habitual Diet in Female Collegiate Dancers: The Intercollegiate Artistic Athlete Research Assessment (TIAARA) Study. [PDF]

Nutrients
Saenz C, Sanders DJ, Brooks SJ, Bracken L, Jordan A, Stoner J, Vatne E, Wahler M, Brown AF.   +8 more
europepmc   +1 more source

Portable Motion-Analysis Device for Upper-Limb Research, Assessment, and Rehabilitation in Non-Laboratory Settings. [PDF]

IEEE J Transl Eng Health Med, 2019
Sohn WJ, Sipahi R, Sanger TD, Sternad D.
europepmc   +1 more source

Collaboration through Research: The Multimethod Church-Based Assessment Process

, 2003
Amy W. Dominguez, Mark R. McMinn
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Applying a User-Centered Design Framework to Develop a Remote Research Assessment Protocol for a Randomized Clinical Trial for Toddlers with Early Autism Characteristics. [PDF]

J Autism Dev Disord
Tagavi DM, Dai YG, Berger NI, Petruccelli M, Scott SE, Oosting D, Howard M, Carter AS, Ingersoll B, Wainer AL, Broder-Fingert S, Stone WL.   +11 more
europepmc   +1 more source

Development of the PROMIS-based Research Assessment and Clinical Tool-Fatigue (ReACT-F). [PDF]

Support Care Cancer, 2019
Dickinson KA, Kelly DL, Lai JS, Saligan LN.   +3 more
europepmc   +1 more source